‘India’s Safest COVID-19 Vaccine’ Receives Approval for Human Trials! – Health Minister Reveals Details

Home > News Shots > India news
By |

India has been witnessing an increase in the number of coronavirus cases. Currently the numbers have crossed 9 lakh and the medical experts have been trying to develop a vaccine indigenously, in order to combat the pandemic.

India’s second vaccine, Zydus Cadila’s ZyCoV-D was being developed in Ahmedabad. While the race to find a dosage that has been prepared from scratch within the country, this drug received approvals to start clinical trials phase I and II.
This was announced by Health Minister Dr.Harsh Vardhan on twitter. “ZyCoV-D, the plasmid DNA vaccine designed & developed by @ZydusUniverse & partially funded by @DBTIndia has initiated Phase I/ II clinical trials in healthy subjects, making it the first indigenously developed vaccine for #COVID19 to be administered in humans in India.@IndiaDST,” his tweet read.
Pre-clinical trials of this drug were performed on animals such as mice, rabbits, rats, who developed anti-bodied to fight the virus. TOI also reported that by far, it is the most safest and “well-tolerated” vaccine.
The other vaccine, COVAXIN produced by Bharat Biotech is also yet to commence testing.

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      

OTHER NEWS SHOTS

RELATED NEWS STORIES